Even Medical Marijuana Research is Set to Benefit from Banking Reform

Lawmakers are once again trying to give the green light to cannabis banking legislation in states where it’s legal. With classic banking services potentially becoming available for marijuana dispensaries, how will this impact the sale of medical-grade cannabis products? Michael Sassano, the Chairman and CEO at Somai Pharmaceuticals weighs in.

With these potential developments, it begs the question: does this banking reform open the door for a more frictionless research pipeline? Michael shares some interesting statistics on where things stand researching cannibanoids for pharmaceuticals and medical applications.